Total Payments
$26,134
2024 Payments
$5,093
Companies
65
Transactions
1,642
Medicare Patients
1,104
Medicare Billing
$103,412
Payment Breakdown by Category
Food & Beverage$26,026 (99.6%)
Education$107.73 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $26,026 | 1,637 | 99.6% |
| Education | $107.73 | 5 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $3,706 | 206 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $3,215 | 143 | $0 (2024) |
| GlaxoSmithKline, LLC. | $2,512 | 135 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,311 | 117 | $0 (2024) |
| Novo Nordisk Inc | $1,233 | 86 | $0 (2024) |
| Allergan, Inc. | $1,139 | 100 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,102 | 64 | $0 (2024) |
| Bausch Health US, LLC | $1,097 | 82 | $0 (2024) |
| Axsome Therapeutics, Inc. | $887.15 | 49 | $0 (2024) |
| Lilly USA, LLC | $848.47 | 64 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,093 | 246 | ABBVIE INC. ($1,238) |
| 2023 | $4,644 | 235 | AbbVie Inc. ($823.32) |
| 2022 | $2,982 | 193 | ABBVIE INC. ($717.54) |
| 2021 | $4,000 | 248 | AbbVie Inc. ($769.76) |
| 2020 | $2,656 | 206 | GlaxoSmithKline, LLC. ($315.53) |
| 2019 | $2,240 | 179 | GlaxoSmithKline, LLC. ($307.10) |
| 2018 | $2,632 | 182 | Allergan Inc. ($513.68) |
| 2017 | $1,886 | 153 | AstraZeneca Pharmaceuticals LP ($316.49) |
All Payment Transactions
1,642 individual payment records from CMS Open Payments — Page 1 of 66
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $8.65 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $17.51 | General |
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $13.31 | General |
| 12/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Respiratory | ||||||
| 12/11/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: RESPIRATORY | ||||||
| 12/09/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $119.23 | General |
| Category: Oncology | ||||||
| 12/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: NEUROSCIENCE | ||||||
| 12/06/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $5.37 | General |
| Category: Diabetes | ||||||
| 12/02/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: Inflammation | ||||||
| 12/02/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $10.96 | General |
| Category: NEUROSCIENCE | ||||||
| 11/27/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $28.46 | General |
| Category: Neuroscience | ||||||
| 11/27/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $6.30 | General |
| Category: RESPIRATORY | ||||||
| 11/25/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $27.94 | General |
| Category: Oncology | ||||||
| 11/22/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/20/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $26.86 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Respiratory | ||||||
| 11/18/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $5.01 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $4.87 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $22.03 | General |
| Category: Opioid Analgesic | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 248 | 413 | $60,505 | $26,072 |
| 2022 | 7 | 255 | 397 | $55,346 | $26,356 |
| 2021 | 10 | 331 | 507 | $52,276 | $29,262 |
| 2020 | 8 | 270 | 428 | $45,481 | $21,722 |
Total Patients
1,104
Total Services
1,745
Medicare Billing
$103,412
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 89 | 216 | $29,680 | $11,025 | 37.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 59 | 93 | $17,910 | $7,243 | 40.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 52 | 52 | $10,140 | $6,429 | 63.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 11 | 11 | $1,320 | $833.91 | 63.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 13 | 13 | $650.00 | $383.63 | 59.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 11 | 11 | $550.00 | $99.12 | 18.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 13 | 17 | $255.00 | $57.97 | 22.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 93 | 203 | $27,405 | $11,537 | 42.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 53 | 81 | $15,390 | $6,859 | 44.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 46 | 46 | $8,970 | $5,859 | 65.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 19 | 19 | $2,090 | $1,335 | 63.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 21 | 21 | $1,050 | $598.50 | 57.0% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 11 | 12 | $216.00 | $116.23 | 53.8% |
| 81002 | Urinalysis, manual test | Office | 2022 | 12 | 15 | $225.00 | $51.78 | 23.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 81 | 182 | $21,595 | $10,726 | 49.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 57 | 95 | $15,980 | $8,201 | 51.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 51 | 51 | $8,195 | $6,616 | 80.7% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 18 | 18 | $1,800 | $1,196 | 66.4% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 24 | 24 | $1,440 | $931.44 | 64.7% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 22 | 22 | $1,320 | $853.82 | 64.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 22 | 22 | $1,100 | $363.44 | 33.0% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 16 | 32 | $576.00 | $310.72 | 53.9% |
| 81002 | Urinalysis, manual test | Office | 2021 | 18 | 18 | $270.00 | $62.64 | 23.2% |
| 91301 | Sarscov2 vac 100mcg/0.5ml im | Office | 2021 | 22 | 43 | $0.43 | $0.43 | 100.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 93 | 218 | $23,980 | $9,845 | 41.1% |
About Dr. Daniel Arenos, M.D
Dr. Daniel Arenos, M.D is a Family Medicine healthcare provider based in Albany, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1285604231.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Arenos, M.D has received a total of $26,134 in payments from pharmaceutical and medical device companies, with $5,093 received in 2024. These payments were reported across 1,642 transactions from 65 companies. The most common payment nature is "Food and Beverage" ($26,026).
As a Medicare-enrolled provider, Arenos has provided services to 1,104 Medicare beneficiaries, totaling 1,745 services with total Medicare billing of $103,412. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Albany, NY
- Active Since 01/24/2006
- Last Updated 03/06/2019
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1285604231
Products in Payments
- TRELEGY ELLIPTA (Drug) $1,757
- FARXIGA (Drug) $1,709
- VRAYLAR (Drug) $1,677
- UBRELVY (Drug) $1,576
- Auvelity (Drug) $887.15
- JARDIANCE (Drug) $868.23
- TRINTELLIX (Drug) $777.25
- QULIPTA (Drug) $767.67
- APLENZIN (Drug) $761.81
- Ozempic (Drug) $736.21
- Cologuard Collection Kit (Device) $732.82
- NURTEC ODT (Drug) $385.55
- Edarbyclor (Drug) $382.63
- AIRSUPRA (Drug) $380.81
- Edarbi (Drug) $371.60
- BREZTRI (Drug) $361.58
- ELIQUIS (Drug) $335.43
- WELLBUTRIN (Drug) $335.38
- SYNTHROID (Drug) $335.13
- GEMTESA (Drug) $333.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Albany
Bruce Houston, D.o, D.O
Family Medicine — Payments: $23,151
Family Medicine $23,151
Mr. Michael Satchell, Md, MD
Family Medicine — Payments: $20,355
Family Medicine $20,355
Theodore Hausler, D.o, D.O
Family Medicine — Payments: $16,979
Family Medicine $16,979
Stephanie Williams, M.d, M.D
Family Medicine — Payments: $16,489
Family Medicine $16,489
Mr. Derek Heard, Md, MD
Family Medicine — Payments: $15,696
Family Medicine $15,696
Dr. Latifat Agbeja, M.d, M.D
Family Medicine — Payments: $14,194
Family Medicine $14,194